20.07.2022: The recently published update of WHO’s analyses of the global clinical antibacterial pipeline, now integrated within the Global AMR R&D Hub’s Dynamic Dashboard, again highlights a major gap in the development of needed new innovative antibiotics to address growing public health needs globally. Click to find out more.
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.